International
Dragon Pharma
Dragon Pharma Ovagen 20 mg EDL Tripeptide Research Vial
Injection · 20 mg · vial
Out of stock
Dragon Pharma Ovagen is the EDL tripeptide, a short bioregulator supplied as a 20 mg lyophilized vial for research. Vendor material positions it as a hepatic and gastrointestinal tissue peptide, and the family format is a one to three week block repeated once or twice a year.
GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file. Ovagen 20 mg for sale with U.S. domestic and international shipping.
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted
Product overview
Dragon Pharma Ovagen 20 mg EDL Peptide Vial
Dragon Pharma Ovagen is a 20 mg lyophilized vial of the EDL tripeptide, the shortest member of the bioregulator series that also contains Livagen and Testagen. The vendor description gives it a hepatic and gastrointestinal tissue accent, and the same wording appears across several vendor pages, which is a description rather than a reported outcome. The pack is one vial of powder for reconstitution with bacteriostatic water.
- 20 mg lyophilized powder in a single vial - research use
- Short regulatory tripeptide, sequence EDL
- GMP-manufactured and HPLC-verified - COA on file per batch
- U.S. domestic and international shipping
How Ovagen Works
What the sources support is modest and should be stated plainly. The family background is cell-level: short peptides of this generation are studied in relation to histone proteins and the transcription accessibility of promoters, which is a dish-level mechanism and not a human endpoint. For Ovagen itself there are no randomised human studies, no published half-life and no approved indication, and the hepatic-gastrointestinal targeting is vendor positioning. No direct entry for the peptide was found in the WADA prohibited list, and the fact sheet marks that finding as not confirmed, so it is not evidence of permission either. The liver line of the same series is described on the Livagen page.
Reconstitution & Storage
Add bacteriostatic water against the vial wall and swirl, do not shake. A 20 mg vial in 2 ml gives 10 mg/ml, where 1 mg is 0.1 ml or 10 units on a U-100 syringe; with 1 ml of diluent the vial gives 20 mg/ml and 1 mg is 0.05 ml. Vendor material mentions 0.5-2 mg per day, and the family format is a one to three week block, so a vial at 1 mg per day lasts 20 days. Store the powder at 2-8 C away from light and use a solution within about 28 to 30 days.
Quality & Authenticity
Every batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis held per batch. Keep the vial upright and protected from light, and avoid repeated freeze-thaw cycles. The testicular member of the same family is described on the Testagen page, and the pineal peptide is on the Epitalon page.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | Ovagen |
| Generic Name | Short regulatory tripeptide, sequence EDL |
| Manufacturer | Dragon Pharma |
| Dosage | 20 mg per vial |
| Package | 1 lyophilized vial |
| Drug Class | Research peptide, short bioregulator |
| Half-Life | Not established in humans |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
Research compounds only. Consult a healthcare professional before any use. Amounts shown are vendor and project-family practice, not clinical doses.
FAQ
Before you ask
Questions, answered
Ovagen is the EDL tripeptide, a short bioregulator that vendor material places in a hepatic and gastrointestinal context. The research background of the family is cell-level work on histone proteins and promoter accessibility, not human outcomes. There is no approved indication, no human trial program and no pharmacokinetic profile for the peptide, so it is a laboratory material rather than a treatment.
Draw bacteriostatic water and add it against the wall of the vial, then swirl instead of shaking. Two ml of diluent in a 20 mg vial gives 10 mg/ml, where 1 mg is 0.1 ml or 10 units on a U-100 syringe. One ml gives 20 mg/ml and 1 mg is 0.05 ml, which calls for a low-volume syringe. Hold the solution at 2-8 C and use it within about 28 to 30 days.
That depends on the amount used, and the honest answer is that no human dose is established. Vendor material mentions 0.5-2 mg per day, and the project family format is a one to three week block repeated once or twice a year. At 1 mg per day a 20 mg vial covers 20 days, which comfortably exceeds one family block; at 2 mg per day it covers 10 days.
Injection site pain, redness and itching are the most described effects for this peptide family, and they are managed by rotating sites and keeping the technique clean. An allergic reaction to any peptide is possible, so a small test amount first is sensible. There are no long-term human safety data, because the family has not been through randomised human trials.
No. It has no approved medical use and no human outcome data, so it cannot stand in for any prescribed treatment. Anyone dealing with a real liver or gut problem needs a clinician and actual diagnostics. In a research context the peptide is simply a material in a vial, and the 17-alpha-methyl orals sold elsewhere on the site carry far more direct hepatic relevance.
Keep the lyophilized vial at 2-8 C, protected from light, and do not freeze the powder repeatedly. Once reconstituted, hold the solution at 2-8 C and use it within about 28 to 30 days. GenXXLGear ships Ovagen 20 mg with U.S. domestic and international shipping, and each batch carries a Certificate of Analysis from third-party HPLC testing.
No reviews yet
Be the first to share your experience with Dragon Pharma Ovagen 20 mg EDL Tripeptide Research Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
U.S Domestic
Available Domestic